Artificially low mild cognitive impairment to normal reversion rate in the Alzheimer's Disease Neuroimaging Initiative

Abstract

We examined reasons for low mild cognitive impairment (MCI)‐to‐cognitively normal (CN) reversion rates in the Alzheimer's Disease Neuroimaging Initiative (ADNI).

Document Details

Document Type
Pub Defense Publication
Publication Date
Jan 02, 2019
Source ID
10.1016/j.jalz.2018.10.008

Entities

People

  • Alexandra J. Weigand
  • Amy J. Jak
  • Christina G. Wong
  • David P. Salmon
  • Douglas R. Galasko
  • Emily C. Edmonds
  • For The Alzheimer’s Disease Neuroimaging Initiative*
  • Joel S. Eppig
  • Kelsey R Thomas
  • Lisa Delano‐wood
  • Mark W. Bondi
  • Steven D. Edland

Organizations

  • Alzheimer's Association
  • Alzheimer's Disease Neuroimaging Initiative
  • National Institutes of Health
  • San Diego State University
  • United States Department of Defense
  • University of California, San Diego

Tags

Fields of Study

  • Medicine
  • Psychology

Readers

  • Gulf War Illness and Chronic Multisymptom Illness in Veterans.
  • Toxicology/Environmental Toxicology